SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-001885
Filing Date
2020-02-20
Accepted
2020-02-20 16:06:26
Documents
15
Period of Report
2020-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K corcpetform8-k02x20x20.htm   iXBRL 8-K 41166
2 EXHIBIT 99.1 exhibit991pressrelease.htm EX-99.1 185157
  Complete submission text file 0001628280-20-001885.txt   387937

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20200220.xsd EX-101.SCH 4604
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20200220_cal.xml EX-101.CAL 642
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20200220_def.xml EX-101.DEF 1492
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20200220_lab.xml EX-101.LAB 27453
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20200220_pre.xml EX-101.PRE 14189
15 EXTRACTED XBRL INSTANCE DOCUMENT corcpetform8-k02x20x20_htm.xml XML 4600
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 20635081
SIC: 2834 Pharmaceutical Preparations